METTL3 suppresses neuropathic pain via modulating N6-methyladenosine-dependent primary miR-150 processing
Abstract Methyltransferase-like 3 (METTL3)-modulated N6-methyladenosine (m6A) was recently identified as an important epigenetic regulation type during RNA processing and contributes to multiple pathological processes. Neuropathic pain (NP) is induced by a lesion of the somatosensory nervous system,...
Main Authors: | Le Zhang, Xin Zhao, Jing Wang, Yanwu Jin, Moxuan Gong, Yuyang Ye, Peilong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-02-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-022-00880-2 |
Similar Items
-
METTL3 Induces AAA Development and Progression by Modulating N6-Methyladenosine-Dependent Primary miR34a Processing
by: Lintao Zhong, et al.
Published: (2020-09-01) -
Solution structure of the RNA recognition domain of METTL3-METTL14 N6-methyladenosine methyltransferase
by: Jinbo Huang, et al.
Published: (2018-03-01) -
Suppression of miR-155 attenuates neuropathic pain by inducing an M1 to M2 switch in microglia
by: Yanxiang Zhang, et al.
Published: (2020-03-01) -
MicroRNA-150 (miR-150) and Diabetic Retinopathy: Is miR-150 Only a Biomarker or Does It Contribute to Disease Progression?
by: Gladys Y.-P. Ko, et al.
Published: (2022-10-01) -
METTL3-Dependent N6-Methyladenosine Modification Programs Human Neural Progenitor Cell Proliferation
by: Yuan Zhao, et al.
Published: (2023-10-01)